Filing Flows › Inspire Medical Systems (INSP) › Q2 2026 › vs Q1 2026
Inspire Medical Systems (INSP) Q2 2026 vs Q1 2026 (quarter over quarter)
Inspire Medical Systems's revenue fell $4.0M (-2%) from $205M in Q1 2026 to $201M in Q2 2026.
Inspire Medical Systems, Q2 2026: revenue $201M (-8% year over year), operating margin -0.3%, net earnings $314K, operating cash flow $23.2M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 7.0% | 1.5% | +5.5 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $201M | $205M | −$4.0M | -2% |
| Other income, net | $3.6M | $3.5M | $114K | +3% |
| Costs & expenses | $204M | $219M | −$15.2M | -7% |
| Operating costs | $201M | $206M | −$4.6M | -2% |
| Income tax | $2.8M | $13.7M | −$10.9M | -80% |
| Net earnings | $314K | −$11.3M | $11.6M | — |
| Cost of revenue | $29.1M | $27.7M | $1.5M | +5% |
| Research & development | $24.7M | $25.8M | −$1.1M | -4% |
| SG&A | $147M | $152M | −$4.9M | -3% |
| Operating cash sources | $36.1M | $24.5M | $11.6M | +47% |
| Depreciation & amortization | $4.6M | $5.1M | −$513K | -10% |
| Share-based compensation | $31.2M | $30.7M | $511K | +2% |
| Working capital & other | $12.9M | $11.7M | $1.2M | +11% |
| Operating cash flow | $23.2M | $12.8M | $10.4M | +81% |
| Free cash flow (OCF − capex) | $14.1M | $3.1M | $10.9M | +350% |
| Capital expenditures | $9.2M | $9.7M | −$566K | -6% |
Questions
How much did Inspire Medical Systems's revenue grow quarter over quarter in Q2 2026?
Inspire Medical Systems's revenue fell $4.0M (-2%) from $205M in Q1 2026 to $201M in Q2 2026.